Brief: Tenaya Therapeutics Reports First Quarter 2023 Financial Results And Provides Business Update

Tenaya Therapeutics

10/05/2023 22:54

Tenaya Therapeutics Inc  TNYA.O :
    * TENAYA THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND  PROVIDES BUSINESS UPDATE
    * TENAYA THERAPEUTICS INC - TN-201 RECEIVED FAST TRACK
DESIGNATION
FROM FDA
    * TENAYA THERAPEUTICS INC - DOSING COMPLETE IN PHASE 1
CLINICAL
TRIAL OF TN-301; DATA EXPECTED IN SECOND HALF 2023
    * TENAYA THERAPEUTICS INC - AS OF MARCH 31, 2023, CASH, CASH
EQUIVALENTS AND INVESTMENTS IN MARKETABLE SECURITIES WERE $173.6
MILLION
    * TENAYA THERAPEUTICS - SEES CURRENT CASH, CASH EQUIVALENTS
&
INVESTMENTS IN MARKETABLE SECURITIES WILL BE SUFFICIENT TO FUND
CO INTO H1 OF 2025

Source text for Eikon:  ID:nGNX6XklR5 
Further company coverage:  TNYA.O